Oncology News and Research

RSS

Oncology, meaning bulk, mass, or tumor, and the suffix ''-logy'', meaning "study of") is a branch of medicine that deals with tumors (cancer). A medical professional who practices oncology is an ''oncologist''.

A single round of chemotherapy has no effect on sperm count, say researchers

Men with early-stage testicular can safely undergo one round of post-operative chemotherapy or radiotherapy without a long-term negative effect on sperm count.

25 Feb 2019

New analysis highlights increasing focus of early-stage clinical trials on rare cancers

The proportion of early-stage drug trials tackling the biggest cancer killers has declined sharply since the early 1990s as less common tumor types receive increasing attention, according to new research to be presented during the International Congress on Targeted Anticancer Therapies 2019, taking place from today to 27 February in Paris, France.

25 Feb 2019

Sperm quality not affected by one course of postoperative treatment for early testicular cancer

Men with early stage testicular cancer can safely receive one course of chemotherapy or radiotherapy after surgery without it having a long-term effect on their sperm count, according to a study published in the leading cancer journal Annals of Oncology today (Monday).

25 Feb 2019

Researchers investigate how marijuana and tobacco co-use affects quit attempts by smokers

Tobacco isn't the only thing being smoked in the Deep South, and for many, it's only half of their habit.

23 Feb 2019

CPRIT awards nearly $20 million to The University of Texas MD Anderson Cancer Center

The University of Texas MD Anderson Cancer Center today was awarded $19.6 million from the Cancer Prevention and Research Institute of Texas (CPRIT) to support research, recruitment and prevention efforts.

22 Feb 2019

Breast cancer study: Family-history-based models perform better than non-family-history based models

A team of researchers led by Columbia University Mailman School of Public Health Professor Mary Beth Terry, PhD, evaluated four commonly used breast cancer prediction models and found that family-history-based models perform better than non-family-history based models, even for women at average or below-average risk of breast cancer.

22 Feb 2019

New identified biomarker predicts patients who might benefit from HER2-targeted agents

In an effort to further individualize therapy and avoid over-treating patients, researchers at the Johns Hopkins Kimmel Cancer Center report a new study using PET scans has identified a biomarker that may accurately predict which patients with one type of HER2-positive breast cancer might best benefit from standalone HER2-targeted agents, without the need for standard chemotherapy.

22 Feb 2019

Consumption of allium vegetables linked to reduced colorectal cancer risk

Consumption of allium vegetables—which include garlic, leeks, and onions—was linked with a reduced risk of in colorectal cancer in a study of men and women in China.

21 Feb 2019

Cervical cancer could be eradicated by 2100

Scaling up the human papillomavirus (HPV) vaccine could eradicate cervical cancer in high-income countries within 30 years, according to a new study.

21 Feb 2019

Johns Hopkins scientists find new compound that may prevent reperfusion injury

In a strategic search, Johns Hopkins scientists created and screened a library of 45,000 new compounds containing chemical elements of widely used immune system suppressants, and say they found one that may prevent reperfusion injury, a tissue-damaging and common complication of surgery, heart attack and stroke.

21 Feb 2019

Why melanoma tumors in the brain may be worse?

Melanoma tumors that have spread to the brain are equipped to thwart immunotherapies and targeted therapies that succeed against tumors growing in other sites.

20 Feb 2019

New AI can identify, predict development of different combinations of cancer symptoms

Cancer patients who undergo chemotherapy could soon benefit from a new AI that is able to identify and predict the development of different combinations of symptoms - helping to alleviate much of the distress caused by their occurrence and severity.

20 Feb 2019

Growing number of cancer survivors, fewer providers point to challenge in meeting care needs

An aging population, a growing number of cancer survivors, and a projected shortage of cancer care providers will result in a challenge in delivering the care for cancer survivors in the United States if systemic changes are not made, according to a commentary in the Journal of the National Cancer Institute.

20 Feb 2019

Clinical trial researchers can initiate advance care planning discussions to help cancer patients

Cancer clinical trials are an important option for patients with cancer. Yet, once a trial ends, patients still need care plans.

20 Feb 2019

Rapid expansion of interventions could prevent up to 13 million cases of cervical cancer within 50 years

Cervical cancer could be eliminated as a public health problem in most countries by the end of the century by rapid expansion of existing interventions, according to a modeling study published in The Lancet Oncology journal.

20 Feb 2019

First molecular test predicts treatment response for kidney cancer

Immunotherapy drugs such as PD-L1 checkpoint inhibitors represent the front-line treatment for kidney cancer. But immunotherapy is expensive, benefits only a subset of patients and is futile in the majority of patients.

19 Feb 2019

Female adolescent blood donors more likely to have iron deficiency and related anemia

Female adolescent blood donors are more likely to have low iron stores and iron deficiency anemia than adult female blood donors and nondonors, which could have significant negative consequences on their developing brains, a new study led by Johns Hopkins researchers suggests.

19 Feb 2019

Early marker of cardiac damage triggered by cancer treatment identified

Every year, 4 million new cases of cancer are diagnosed in Europe. Advances in cancer treatment sometimes come at the cost of major adverse effects, and one of the most prominent is cardiotoxicity. Myocardial toxicity affects as many as 25% of patients undergoing treatment with commonly used anticancer drugs.

19 Feb 2019

Harnessing the evolutionary games played by cancer cells to advance therapies

Despite rapid advances in targeted therapies for cancer, tumors commonly develop resistance to treatment. When resistance emerges, tumor cells continue to grow unchecked, despite all attempts to slow cancer progression.

19 Feb 2019

Researchers report progress in the treatment of aggressive brain tumors

Cancer researchers at the University of Bonn have reported significant progress in the treatment of glioblastoma. About one third of all patients suffer from a particular variant of this most common and aggressive brain tumor.

18 Feb 2019

Oncology News and Research

Further Reading

A single round of chemotherapy has no effect on sperm count, say researchers

New analysis highlights increasing focus of early-stage clinical trials on rare cancers

Sperm quality not affected by one course of postoperative treatment for early testicular cancer

Researchers investigate how marijuana and tobacco co-use affects quit attempts by smokers

CPRIT awards nearly $20 million to The University of Texas MD Anderson Cancer Center

Breast cancer study: Family-history-based models perform better than non-family-history based models

New identified biomarker predicts patients who might benefit from HER2-targeted agents

Consumption of allium vegetables linked to reduced colorectal cancer risk

Cervical cancer could be eradicated by 2100

Johns Hopkins scientists find new compound that may prevent reperfusion injury

Why melanoma tumors in the brain may be worse?

New AI can identify, predict development of different combinations of cancer symptoms

Growing number of cancer survivors, fewer providers point to challenge in meeting care needs

Clinical trial researchers can initiate advance care planning discussions to help cancer patients

Rapid expansion of interventions could prevent up to 13 million cases of cervical cancer within 50 years

First molecular test predicts treatment response for kidney cancer

Female adolescent blood donors more likely to have iron deficiency and related anemia

Early marker of cardiac damage triggered by cancer treatment identified

Harnessing the evolutionary games played by cancer cells to advance therapies

Researchers report progress in the treatment of aggressive brain tumors

Event guide: 10th CAR-TCR Summit eBook

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo

Latest News